Improving MRI techniques for evaluating brain tumors.
Quantitative Steady-State and Dynamic Metabolic MRI for Evaluating Patients with Glioma
['FUNDING_R01'] · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · NIH-11035162
This study is working on improving MRI scans for people with glioma, a type of brain tumor, by creating new tools that make the imaging process easier and more reliable, so doctors can better understand the tumor and provide better care for patients.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO (nih funded) |
| Locations | 1 site (SAN FRANCISCO, UNITED STATES) |
| Trial ID | NIH-11035162 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing MRI metabolic imaging methods for patients with glioma, a type of brain tumor. The UCSF and GE team aims to develop advanced hardware and software tools that will automate the imaging process, ensuring consistent results regardless of the operator. By streamlining data processing and interpretation, the project will facilitate better assessment of tumor characteristics over time. The goal is to provide more accurate and comprehensive imaging that can improve patient care.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals aged 21 and older who are diagnosed with glioma and undergoing active follow-up.
Not a fit: Patients with other types of brain tumors or those who are not undergoing active follow-up may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more precise evaluations of gliomas, potentially improving treatment outcomes for patients.
How similar studies have performed: Previous research has shown promise in enhancing MRI techniques for tumor evaluation, indicating that this approach could build on established methods.
Where this research is happening
SAN FRANCISCO, UNITED STATES
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO — SAN FRANCISCO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: XU, DUAN — UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
- Study coordinator: XU, DUAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.